These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10463359)
1. Apolipoprotein E and presenilin-1 genotypes in Huntington's disease. Panas M; Avramopoulos D; Karadima G; Petersen MB; Vassilopoulos D J Neurol; 1999 Jul; 246(7):574-7. PubMed ID: 10463359 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease. Saft C; Andrich JE; Brune N; Gencik M; Kraus PH; Przuntek H; Epplen JT J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1692-6. PubMed ID: 15548484 [TBL] [Abstract][Full Text] [Related]
3. Effect of Apolipoprotein E Genotypes on Huntington's Disease Phenotypes in a Han Chinese Population. Li XY; Zhang YB; Xu M; Cheng HR; Dong Y; Ni W; Li HL; Wu ZY Neurosci Bull; 2019 Aug; 35(4):756-762. PubMed ID: 30887245 [TBL] [Abstract][Full Text] [Related]
4. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
5. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease. Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
9. A study of potential interactive genetic factors in Huntington's disease. Panegyres PK; Beilby J; Bulsara M; Toufexis K; Wong C Eur Neurol; 2006; 55(4):189-92. PubMed ID: 16772714 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients. Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY Gene; 2019 Oct; 715():144011. PubMed ID: 31357022 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Beilby JP; Hunt CC; Palmer LJ; Chapman CM; Burley JP; McQuillan BM; Thompson PL; Hung J; Stroke; 2003 Apr; 34(4):869-74. PubMed ID: 12637699 [TBL] [Abstract][Full Text] [Related]
12. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007 [TBL] [Abstract][Full Text] [Related]
13. The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Ezquerra M; Blesa R; Tolosa E; Lopez Pousa S; Aguilar M; Peña J; Van Broeckhoven C; Ballesta F; Oliva R Neurosci Lett; 1997 May; 227(3):201-4. PubMed ID: 9185685 [TBL] [Abstract][Full Text] [Related]
14. Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease. Al-Meghaiseeb ES; Al-Otaibi MM; Al-Robayan A; Al-Amro R; Al-Malki AS; Arfin M; Al-Asmari AK World J Gastroenterol; 2015 Jan; 21(3):897-904. PubMed ID: 25624723 [TBL] [Abstract][Full Text] [Related]
15. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians. Souza DR; de Godoy MR; Hotta J; Tajara EH; Brandão AC; Pinheiro Júnior S; Tognola WA; dos Santos JE Braz J Med Biol Res; 2003 Jul; 36(7):919-23. PubMed ID: 12845379 [TBL] [Abstract][Full Text] [Related]
16. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes. Zareparsi S; Kaye J; Camicioli R; Grimslid H; Oken B; Litt M; Nutt J; Bird T; Schellenberg G; Payami H Ann Neurol; 1997 Oct; 42(4):655-8. PubMed ID: 9382478 [TBL] [Abstract][Full Text] [Related]
17. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817 [TBL] [Abstract][Full Text] [Related]
18. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea]. Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360 [TBL] [Abstract][Full Text] [Related]
19. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]